Evaluating the Impact of Interventions and Improvements in Outpatient Intravenous Infusion Therapy at a Hospital in China: A Comprehensive Analysis of Prescription Patterns and Safety Measures
Ran Sang,Manxue Jiang,Qiuju Zhao,Lingti Kong
DOI: https://doi.org/10.2147/rmhp.s451516
2024-03-09
Risk Management and Healthcare Policy
Abstract:Ran Sang, 1, 2 Manxue Jiang, 1, 2 Qiuju Zhao, 2 Lingti Kong 1, 2 1 Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233004, People's Republic of China; 2 School of Pharmacy, Bengbu Medical University, Bengbu, 233030, People's Republic of China Correspondence: Lingti Kong, Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University, 287 Changhuai Road, Longzihu District, Bengbu, Anhui, 233004, People's Republic of China, Tel +865523086297, Email Background: The excessive use of intravenous infusion in China was once a serious problem, but in recent years, attention has been paid to the phenomenon, and the government has implemented several policies to solve the problem, which has been gradually improved. Aim: This study focuses on evaluating the impact of ongoing interventions and improvements in outpatient intravenous infusion therapy. Methods: From January 2016 to December 2022, we conducted a study to gather annual data on intravenous infusion prescriptions. A data questionnaire, encompassing information on departments, clinical diagnosis, and infusion drugs, was developed for this purpose. We analyzed the changing trends of Top 10 clinical departments with higher intravenous infusion usage rates and Top 10 drugs used. We also evaluated the compliance of intravenous infusion prescriptions with management regulations and drug instructions, for further intervention in the future. Results: The analysis of intravenous infusion prescription rates revealed a gradual decrease from 10.89% to 5.63%. This reduction was statistically significant (P < 0.05). High levels of intravenous infusion use were consistently observed in emergency surgery and emergency medicine. Commonly administered drugs via infusion included antibacterial drugs, tumor medications, proton pump inhibitors, and injections of traditional Chinese medicine. Inappropriate prescriptions are often characterized by issues related to drug dosage, usage, indication, and selection. Trend analysis of unreasonable types revealed significant improvements in "Diagnosis incomplete/unwritten", "Solvent selection", "Dosing frequency", and "Treatment without indication" (P < 0.05). Conclusion: The findings of this study indicate a gradual improvement in the situation regarding intravenous infusion. However, there are still prevalent instances of unreasonable practices that need to be addressed. Keywords: cross-sectional study, evaluation, analysis, intravenous infusion prescriptions, outpatient In hospitals throughout China, intravenous infusion is widely utilized as a significant method of clinical treatment. 1–4 Reports indicate that in 2019, China consumed a staggering 10.5 billion medical infusion bags, equivalent to 7.5 bottles per person per year, significantly exceeding the international average. The 2020 National Adverse Drug Reaction Monitoring Annual Report reveals that injection administration accounts for 56.7% of all reported adverse drug reactions, with intravenous administration alone contributing to 91.1% of these reactions. 5 Moreover, injections represent 57.0% of the total dosage form, with severe adverse reactions reported in 73.0% of injection cases. 5 Evidently, intravenous administration poses significant risks and potential safety hazards, leading to a higher incidence of adverse reactions during clinical use. 6–9 Furthermore, studies have highlighted the excessive and irrational use of intravenous infusion in China involving antibiotics, traditional Chinese medicine, adjuvant drugs, and parenteral nutrition. 1,4 In a tertiary children's hospital, approximately 30.5–50.1% of intravenous antibiotic prescriptions were inappropriately used for pneumonia, acute bronchitis, fever, and acute upper respiratory infection. 3 In recent years, substantial efforts have been made to enhance medical safety in China. The National Health Commission and various provinces and cities have issued numerous notices aimed at promoting the rational use of medication. 10 The goal is to standardize hospital practices and address the excessive and unjustified use of intravenous infusion to reduce medical risks and alleviate patients' healthcare costs. In 2014, the Anhui Health Commission issued a notice to strengthen supervision of intravenous infusion practices in medical facilities. This notification included a list of 53 prevalent ailments commonly encountered in outpatient and emergency departments that do not require treatment via intravenous infusion. 11 The objective is to mandate healthcare facilities at all leve -Abstract Truncated-
health care sciences & services,health policy & services